A new FDA approval for a first-in-class drug has vaulted Otsuka into immunoglobulin A nephropathy (IgAN), an increasingly competitive kidney disease field targeted by multiple biopharma companies.
Football was a passion for Scott and Emily. Scott went on to work on the Truman State staff and led the North Iowa Area ...